adenosine monophosphate has been researched along with Allergy, Drug in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Bellutti-Enders, F; Hartmann, K; Jamiolkowski, D; Leuppi-Taegtmeyer, A; Manjaly Thomas, ZR; Scherer Hofmeier, K; Steveling-Klein, E | 1 |
| Morris, AM; Wu, PE | 2 |
| Barone, A; Incorvaia, C; Meschi, T; Nouvenne, A; Peveri, S; Pucciarini, F; Ridolo, E | 1 |
| Cowan, J; Flannery, E; McLachlan, C; Ramsay, CM; Taylor, DR | 1 |
| Matsumura, Y; Tan, EM; Vaughan, JH | 1 |
| Djukanovic, R; Finnerty, JP; Holgate, ST | 1 |
1 review(s) available for adenosine monophosphate and Allergy, Drug
| Article | Year |
|---|---|
Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Drug Hypersensitivity; Humans; Immunity, Innate; Immunologic Factors; Indoles; Infliximab; Interleukin 1 Receptor Antagonist Protein; Nitriles; Pandemics; Pneumonia, Viral; Pyrazines; Pyrazoles; Pyrimidines; SARS-CoV-2; Severity of Illness Index | 2020 |
2 trial(s) available for adenosine monophosphate and Allergy, Drug
| Article | Year |
|---|---|
Bronchoprotective and bronchodilator effects of single doses of (S)-salbutamol, (R)-salbutamol and racemic salbutamol in patients with bronchial asthma.
Topics: Adenosine Monophosphate; Adult; Albuterol; Asthma; Bronchi; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Hypersensitivity; Female; Forced Expiratory Volume; Humans; Male; Methacholine Chloride; Middle Aged; Spirometry; Stereoisomerism; Time Factors | 1999 |
Wheal-and-flare responses to intradermally injected adenosine 5'-monophosphate, hypertonic saline, and histamine: comparison of atopic and nonatopic subjects.
Topics: Adenosine Monophosphate; Benzhydryl Compounds; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Double-Blind Method; Drug Hypersensitivity; Histamine; Humans; Hypersensitivity, Immediate; Injections, Intradermal; Random Allocation; Skin; Skin Tests; Sodium Chloride; Terfenadine | 1989 |
4 other study(ies) available for adenosine monophosphate and Allergy, Drug
| Article | Year |
|---|---|
Remdesivir for patients with COVID-19.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Chemical and Drug Induced Liver Injury; COVID-19 Drug Treatment; Critical Care; Drug Hypersensitivity; Humans; SARS-CoV-2; Treatment Outcome | 2021 |
Dermatological manifestations during COVID-19 infection: a case series and discussion on the problem of differential diagnosis.
Topics: Adenosine Monophosphate; Alanine; COVID-19; COVID-19 Drug Treatment; Diagnosis, Differential; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; SARS-CoV-2; Skin Diseases | 2021 |
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Chemical and Drug Induced Liver Injury; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Hypersensitivity; Humans; SARS-CoV-2; Treatment Outcome | 2021 |
Hypersensitivity to histamine and systemic anaphylaxis in mice with pharmacologic beta adrenergic blockade: protection by nucleotides.
Topics: Adenosine; Adenosine Monophosphate; Anaphylaxis; Animals; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Guanine Nucleotides; Histamine; Lethal Dose 50; Mice; Mice, Inbred ICR; Nucleotides; Propranolol | 1976 |